Reactive Oxygen Species: Friends and Foes of Signal Transduction

The maintenance of highly regulated mechanisms to control intracellular levels of reactive oxygen species (ROS) is essential for normal cellular homeostasis. Indeed, most ROS, including free radicals and peroxides, are produced at low level by normal aerobic metabolism and play an important role in the redox-dependent regulation of many signaling processes. In contrast, excessive accumulation of ROS, resulting from an imbalance between ROS production and scavenging, leads to a condition of oxidative stress that can cause extensive oxidative damage to most cellular components, including proteins, lipids, and DNA, and may have pathophysiological consequences. Remarkably, oxidative stress has been clearly implicated in aging and the pathogenesis of several human diseases, including cardiovascular, metabolic, inflammatory and neurodegenerative diseases, and cancer. Thus, ROS may function as friends or foes of signal transduction depending on specific threshold levels and cell context. To highlight the important topics in this evolving field Journal of Signal Transduction presents a Special Issue on the involvement of ROS in physiological and pathological signal transduction processes from prokaryotes to low and high eukaryotes. In particular, the topics covered in this special issue include ROS-mediated signaling in Bacteria (1), the mechanisms by which ROS affect Neurospora crassa light signal transduction (2), the interplay between ROS and mitochondria in the control of cell death and aging (3,4), and cancer progression (5,6), the role of ROS in nuclear transport (7), the interplay between ROS and Ras GTPases (8), the role of ROS in the crosstalk between integrins and cadherins (9), integrin signaling (10), and skeletal muscle signaling (11). These articles describe our current understanding of this field. Furthermore, this Special Issue highlights the importance of gaining a greater understanding of the physiological and pathological role of ROS in the perspective of defining new therapeutic strategies based on redox regulation of signal transduction processes.